Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

BTLA antibody

This anti-BTLA antibody is a Rabbit Polyclonal antibody detecting BTLA in FACS. Suitable for Human.
Catalog No. ABIN7648389

Quick Overview for BTLA antibody (ABIN7648389)

Target

See all BTLA Antibodies
BTLA (B and T Lymphocyte Associated (BTLA))

Reactivity

  • 79
  • 32
  • 2
  • 2
  • 2
  • 1
Human

Host

  • 44
  • 36
  • 10
  • 3
  • 1
  • 1
  • 1
Rabbit

Clonality

  • 52
  • 42
  • 2
Polyclonal

Conjugate

  • 53
  • 6
  • 5
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This BTLA antibody is un-conjugated

Application

  • 48
  • 48
  • 30
  • 13
  • 13
  • 12
  • 11
  • 10
  • 7
  • 6
  • 4
  • 3
  • 2
  • 2
  • 1
Flow Cytometry (FACS)
  • Purpose

    Anti-B And T-Lymphocyte Attenuator (BTLA) Polyclonal Antibody

    Purification

    Antigen-specific affinity chromatography followed by Protein A affinity chromatography

    Isotype

    IgG
  • Application Notes

    For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for one year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
  • Target

    BTLA (B and T Lymphocyte Associated (BTLA))

    Alternative Name

    B And T-Lymphocyte Attenuator

    Background

    CD272, BTLA1, B-and T-lymphocyte-associated protein

    UniProt

    Q7Z6A9

    Pathways

    Cancer Immune Checkpoints
You are here:
Chat with us!